Skip to content

Task

Explore Yemaachi Biotech Research Initiatives

As a healthcare researcher, I explore Yemaachi Biotech's research initiatives, so that I can understand their clinical studies and contributions to cancer research.

Success definition: Given I am on the Yemaachi Biotech homepage When I click on the 'Company' link and then the 'Research' link, followed by the 'Amber Study' heading Then I should see detailed information about the Amber Study's purpose and methodology, specifically how it focuses on liquid biopsies for detecting genomic mutations in women of African descent with advanced breast cancer.

Trajectory

Step 1:

Url (before/after):

https://www.yemaachi.com/

https://www.yemaachi.com/company/

Content (before/after): 

RootWebArea Yemaachi Biotech – Cancer Innovation Shaped by Africa, focused, url='https://www.yemaachi.com/'
    banner
        [108] link, center=(512,65), url='https://www.yemaachi.com/'
            image, url='https://www.yemaachi.com/wp-content/uploads/2023/11/image-1.png'
        list
Show more 
            listitem
                [121] link Company, center=(750,65), url='https://www.yemaachi.com/company/'
            listitem
                [131] link Cancer Network, center=(888,65), url='https://www.yemaachi.com/cancer-network/'
            listitem
                [133] link Research, center=(1015,65), url='https://www.yemaachi.com/research/'
            listitem
                [135] link Services, center=(1112,65), url='https://www.yemaachi.com/services/'
            listitem
                [137] link News, center=(1196,65), url='https://www.yemaachi.com/news/'
        [148] link Contact Us, center=(1449,65), url='https://www.yemaachi.com/#'
    heading Cancer innovation shaped by Africa — for the world
    paragraph
        StaticText Yemaachi is creating and harnessing the world’s most robust cancer knowledge base to develop the next generation of cancer drugs that are effective in diverse populations.
    [164] link Our Company, center=(492,862), url='https://yemaachi.com/company/'
    heading Our work is dedicated to transforming lives through inclusive, innovative science.
    paragraph
        StaticText Yemaachi is pioneering clinical genomic research across Africa across multiple cancer types.
    image, url='https://www.yemaachi.com/wp-content/uploads/2023/11/yemaachi-staff.png'
    heading Yemaachi has an unmatched global team with African roots
    paragraph
        StaticText Yemaachi’s team is made up of scientists, engineers, and business operators with global expertise and African experience building a global biotech company with African roots.
    link Our Team, url='https://yemaachi.com/company/#team'
    heading News
    article
        image, url='https://www.yemaachi.com/wp-content/uploads/2024/10/images-1-300x164.jpeg'
        heading Yemaachi and Institut Pasteur Tunis Forge Oncogenetics Partnership to Sequence and Characterise Inflammatory Breast Cancer in Patients of African Descent
            link Yemaachi and Institut Pasteur Tunis Forge Oncogenetics Partnership to Sequence and Characterise Inflammatory Breast Cancer in Patients of African Descent, url='https://www.yemaachi.com/2024/10/22/yemaachi-and-institut-pasteur-tunis-forge-oncogenetics-partnership/'
        StaticText 
        time
            StaticText Oct 22, 2024
        list
            listitem
                StaticText 
            listitem
                link Announcements, url='https://www.yemaachi.com/category/announcements/'
    article
        image, url='https://www.yemaachi.com/wp-content/uploads/2024/10/m_bioadv_4_1cover-e1729191557957-300x170.jpeg'
        heading Chronogram: an R package for data curation and analysis of infection and vaccination cohort studies
            link Chronogram: an R package for data curation and analysis of infection and vaccination cohort studies, url='https://www.yemaachi.com/2024/10/17/radiologic-patterns-of-distant-organ-metastasis-in-advanced-breast-cancer-patients-prospective-review-of-ct-images-pre-print-3-2/'
        StaticText 
        time
            StaticText Oct 17, 2024
        list
            listitem
                StaticText 
            listitem
                link Publications, url='https://www.yemaachi.com/category/publications/'
    article
        image, url='https://www.yemaachi.com/wp-content/uploads/2024/09/1719058011363-1-300x208.jpeg'
        heading Oxford Nanopore announces participation in the PROGRESS study, with Yemaachi Biotech
            link Oxford Nanopore announces participation in the PROGRESS study, with Yemaachi Biotech, url='https://www.yemaachi.com/2024/09/09/team-sambai-including-yemaachi-biotech-named-as-recipient-of-prestigious-cancer-grand-challenges-award-2/'
        StaticText 
        time
            StaticText Sep 9, 2024
        list
            listitem
                StaticText 
            listitem
                link Announcements, url='https://www.yemaachi.com/category/announcements/'
    article
        image, url='https://www.yemaachi.com/wp-content/uploads/2024/08/Transl-oncol-Yemaachi-e1729192232490-300x180.jpg'
        heading Targeted gene panel sequencing of liquid and tissue biopsies reveals actionable genomic alterations in Ghanaian metastatic breast cancer cases
            link Targeted gene panel sequencing of liquid and tissue biopsies reveals actionable genomic alterations in Ghanaian metastatic breast cancer cases, url='https://www.yemaachi.com/2024/08/21/radiologic-patterns-of-distant-organ-metastasis-in-advanced-breast-cancer-patients-prospective-review-of-ct-images-pre-print-3/'
        StaticText 
        time
            StaticText Aug 21, 2024
        list
            listitem
                StaticText 
            listitem
                link Publications, url='https://www.yemaachi.com/category/publications/'
    link More News, url='https://yemaachi.com/news/'
    contentinfo
        image, url='https://www.yemaachi.com/wp-content/uploads/2022/07/Logo-6.png'
        heading Links
        list
            listitem
                link Company, url='https://www.yemaachi.com/company/'
            listitem
                link Cancer Network, url='https://www.yemaachi.com/cancer-network/'
            listitem
                link Research, url='https://www.yemaachi.com/research-2/'
            listitem
                link Services, url='https://www.yemaachi.com/services/'
            listitem
                link News, url='https://www.yemaachi.com/news/'
            listitem
                link Contact Us, url='https://www.yemaachi.com/contact/'
            listitem
                link Terms of Use, url='https://www.yemaachi.com/terms-of-use/'
            listitem
                link Privacy Notice, url='https://www.yemaachi.com/privacy-notice/'
        heading Contact Us
        list
            listitem
                link +233 502 528 528, url='tel://+233%20502%20528%20528'
            listitem
                link info@yemaachi.com, url='mailto://info@yemaachi.com'
        heading Company
        paragraph
            StaticText 222 Swaniker Street
            StaticText Abelemkpe – Accra
            StaticText GHANA
        paragraph
            StaticText 1250 Connecticut Ave
            StaticText Suite 700
            StaticText Washington DC 20036
            StaticText USA
        paragraph
            StaticText APHRC Campus
            StaticText Kitisuru, Nairobi
            StaticText KENYA
    StaticText We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
    [473] button Cookie settings, center=(1755,1046)
    [474] button ACCEPT, center=(1858,1046)
    StaticText desktop
    generic, atomic
    generic, atomic

RootWebArea Company – Yemaachi Biotech, focused, url='https://www.yemaachi.com/company/'
    banner
        [105] link, center=(512,65), url='https://www.yemaachi.com/'
            image, url='https://www.yemaachi.com/wp-content/uploads/2023/11/image-1.png'
        list
Show more 
            listitem
                [118] link Company, center=(750,65), url='https://www.yemaachi.com/company/'
            listitem
                [128] link Cancer Network, center=(888,65), url='https://www.yemaachi.com/cancer-network/'
            listitem
                [130] link Research, center=(1015,65), url='https://www.yemaachi.com/research/'
            listitem
                [132] link Services, center=(1112,65), url='https://www.yemaachi.com/services/'
            listitem
                [134] link News, center=(1196,65), url='https://www.yemaachi.com/news/'
        [145] link Contact Us, center=(1449,65), url='https://www.yemaachi.com/company/#'
    heading A New Dawn for Health Knowledge in Africa
    paragraph
        StaticText Yem is a Frafra (Northern Ghana) word meaning knowledge. Amaachi is derived from an Ewe (Eastern Ghana) word meaning medicine. Maachi is also Twi (Southern Ghana) phrase meaning good morning. Together, this conveys the meaning of our name Yemaachi: A new dawn for health knowledge in Africa.
    heading Our Work
    paragraph
        StaticText Yemaachi is creating the world’s most diverse cancer bio-database to develop the next generation of cancer drugs that are effective in diverse populations.
    heading Our Vision
    paragraph
        StaticText Yemaachi is working towards a future where precision oncology research, diagnostics, and therapeutics are truly inclusive, for the benefit of people everywhere.
    heading The values we live by
    paragraph
        StaticText Guiding principles shaping our actions daily.
    heading Respect
    paragraph
        StaticText Our work is based on a foundation of mutual respect between researchers and participants
    heading Empower
    paragraph
        StaticText Our research, products and services empower the communities that inspire and support our work
    heading People
    paragraph
        StaticText We maintain an ecosystem that ensures we put people ahead of profit
    heading Excellence
    paragraph
        StaticText We are commited to excellence in every area of our work
    heading Inclusivity
    paragraph
        StaticText We maintain a safe, open and positive environment
    heading Trust
    paragraph
        StaticText Our activities are conducted in a transparent and ethical manner
    heading Advisory Team
    link profile, url='javascript:void(0)'
        image, url='https://www.yemaachi.com/wp-content/uploads/2023/11/Yaw-Bediako-e1701773995490.jpg'
    heading profile
        link profile, url='javascript:void(0)'
            StaticText Yaw Bediako, PhD
    paragraph
        StaticText Co-Founder & CEO | Immunology
    link profile, url='javascript:void(0)'
        image, url='https://www.yemaachi.com/wp-content/uploads/2023/11/David-Hutchful-e1701774185672.jpg'
    heading profile
        link profile, url='javascript:void(0)'
            StaticText David Hutchful, MSc
    paragraph
        StaticText Co-Founder & CTO
    link profile, url='javascript:void(0)'
        image, url='https://www.yemaachi.com/wp-content/uploads/2023/12/8R4A0464copy-scaled-e1701773391468-1024x1024.jpg'
    heading profile
        link profile, url='javascript:void(0)'
            StaticText Joyce Ngoi, MSc
    paragraph
        StaticText Co-Founder | NGS | Technical Services
    link profile, url='javascript:void(0)'
        image, url='https://www.yemaachi.com/wp-content/uploads/2023/12/Yaw-Profic-Pic-Photo.jpeg'
    heading profile
        link profile, url='javascript:void(0)'
            StaticText Yaw Attua-Afari
    paragraph
        StaticText Co-Founder & CFO
    link profile, url='javascript:void(0)'
        image, url='https://www.yemaachi.com/wp-content/uploads/2023/12/leadership-1024x1024.jpg'
    heading profile
        link profile, url='javascript:void(0)'
            StaticText Abdoulaye Diallo, PhD
    paragraph
        StaticText Bioinformatics & Machine Learning
    link profile, url='javascript:void(0)'
        image, url='https://www.yemaachi.com/wp-content/uploads/2023/12/8R4A0438copy-scaled-e1702642405168-1024x1010.jpg'
    heading profile
        link profile, url='javascript:void(0)'
            StaticText Aida Manu, MSc
    paragraph
        StaticText Operations & Compliance
    link profile, url='javascript:void(0)'
        image, url='https://www.yemaachi.com/wp-content/uploads/2024/07/Dr.jpg'
    heading profile
        link profile, url='javascript:void(0)'
            StaticText Akwasi Asabere, PhD
    paragraph
        StaticText Business Development
    link profile, url='javascript:void(0)'
        image, url='https://www.yemaachi.com/wp-content/uploads/2023/12/8R4A0524copy-scaled-e1701774984824-1024x1024.jpg'
    heading profile
        link profile, url='javascript:void(0)'
            StaticText Emmanuella Amoako, MD
    paragraph
        StaticText Clinical Affairs | Oncology
    link profile, url='javascript:void(0)'
        image, url='https://www.yemaachi.com/wp-content/uploads/2023/11/Frank-Onyambu.jpg'
    heading profile
        link profile, url='javascript:void(0)'
            StaticText Frank Onyambu, PhD
    paragraph
        StaticText Training & Capacity Development | Country Representative, Kenya
    link profile, url='javascript:void(0)'
        image, url='https://www.yemaachi.com/wp-content/uploads/2023/12/leadership-1024x1024.jpg'
    heading profile
        link profile, url='javascript:void(0)'
            StaticText Kanny Diallo, PhD
    paragraph
        StaticText Molecular Epidemiology | Representative, Francophone Africa
    link profile, url='javascript:void(0)'
        image, url='https://www.yemaachi.com/wp-content/uploads/2023/12/8R4A0506copy-scaled-e1702642211658-1024x1020.jpg'
    heading profile
        link profile, url='javascript:void(0)'
            StaticText Lily Paemka, MPhil, PhD
    paragraph
        StaticText Human Genetics
    link profile, url='javascript:void(0)'
        image, url='https://www.yemaachi.com/wp-content/uploads/2023/12/SalewaAHeadshots-8-1-scaled-e1702642492195-1024x1024.jpg'
    heading profile
        link profile, url='javascript:void(0)'
            StaticText Salewa Akomolafe, MA
    paragraph
        StaticText Strategy & Planning
    heading Our Investors
    paragraph
        StaticText Yemaachi is backed by global investors, including V8 Capital, AAIC, LifeLine Family Heritage Fund, Y Combinator, Tencent, LoftyInc Capital, VestedWorld, V Square Capital and Ethan Perlstein, committed to our mission of diversifying precision oncology for the benefit of patients everywhere.
    group 1 of 5
        figure
            image Tencent, url='https://www.yemaachi.com/wp-content/uploads/2023/11/Tencent.jpg'
    group 2 of 5
        figure
            image Y Combinator, url='https://www.yemaachi.com/wp-content/uploads/2023/11/Y-Combinator.jpg'
    group 3 of 5
        figure
            image AAIC Investment, url='https://www.yemaachi.com/wp-content/uploads/2023/11/AAIC-Investment.jpg'
    group 4 of 5
        figure
            image VestedWOrld, url='https://www.yemaachi.com/wp-content/uploads/2023/11/VestedWOrld.jpg'
    group 5 of 5
        figure
            image V8 Capital Partners, url='https://www.yemaachi.com/wp-content/uploads/2023/11/V8-Capital-Partners.jpg'
    button Previous slide
    button Next slide
    generic, atomic
    heading Where We Work
    heading Academic & Research Partners
    heading Industry Partners
    heading Non-Profit Partners
    image, url='https://www.yemaachi.com/wp-content/uploads/2023/11/Marcelle-Ruth.jpg'
    image, url='https://www.yemaachi.com/wp-content/uploads/2023/11/Mask-group-1.png'
    image, url='https://www.yemaachi.com/wp-content/uploads/2023/11/Korle-Bu.png'
    image Greater Accra Regional Hospital logo, url='https://www.yemaachi.com/wp-content/uploads/2023/11/Ridge.png'
    image, url='https://www.yemaachi.com/wp-content/uploads/2023/11/cropped-KATH-LogoNEW.webp'
    image, url='https://www.yemaachi.com/wp-content/uploads/2023/11/Meru-Teching-Hospital.jpg'
    image, url='https://www.yemaachi.com/wp-content/uploads/2023/11/Federal-Teaching-Hospital.jpg'
    image, url='https://www.yemaachi.com/wp-content/uploads/2023/11/Amino-Kano.jpg'
    image, url='https://www.yemaachi.com/wp-content/uploads/2023/11/CHU.jpg'
    image, url='https://www.yemaachi.com/wp-content/uploads/2023/12/8R4A0775-1024x683.jpg'
    heading Join Us
    paragraph
        StaticText The Yemaachi team is a talented, passionate, and committed group of scientists, strategists, engineers, and operators.  Open roles will be posted
        link here, url='https://yemaachi.bamboohr.com/careers'
        StaticText .  To send us your resume or inquire about roles not posted, reach out at
        link recruitment@yemaachi.com, url='mailto:recruitment@yemaachi.com'
        StaticText .
    paragraph
        StaticText Yemaachi also offers internships by application for undergraduate and graduate students. Interns get valuable hands-on experience and mentorship and can focus on Finance, Bioinformatics, Molecular Biology, Software Engineering, or Marketing. To apply, please send a resume/CV, cover letter, and a recommendation from your institution or professor to
        link internships@yemaachi.com, url='mailto:internships@yemaachi.com'
        StaticText indicating which domain area you are interested in applying for.
    contentinfo
        image, url='https://www.yemaachi.com/wp-content/uploads/2022/07/Logo-6.png'
        heading Links
        list
            listitem
                link Company, url='https://www.yemaachi.com/company/'
            listitem
                link Cancer Network, url='https://www.yemaachi.com/cancer-network/'
            listitem
                link Research, url='https://www.yemaachi.com/research-2/'
            listitem
                link Services, url='https://www.yemaachi.com/services/'
            listitem
                link News, url='https://www.yemaachi.com/news/'
            listitem
                link Contact Us, url='https://www.yemaachi.com/contact/'
            listitem
                link Terms of Use, url='https://www.yemaachi.com/terms-of-use/'
            listitem
                link Privacy Notice, url='https://www.yemaachi.com/privacy-notice/'
        heading Contact Us
        list
            listitem
                link +233 502 528 528, url='tel://+233%20502%20528%20528'
            listitem
                link info@yemaachi.com, url='mailto://info@yemaachi.com'
        heading Company
        paragraph
            StaticText 222 Swaniker Street
            StaticText Abelemkpe – Accra
            StaticText GHANA
        paragraph
            StaticText 1250 Connecticut Ave
            StaticText Suite 700
            StaticText Washington DC 20036
            StaticText USA
        paragraph
            StaticText APHRC Campus
            StaticText Kitisuru, Nairobi
            StaticText KENYA
    StaticText We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
    [1056] button Cookie settings, center=(1755,1046)
    [1057] button ACCEPT, center=(1858,1046)
    StaticText desktop
    generic, atomic
    generic, atomic

Reasoning for action: By clicking on the 'Company' link, I am accessing more detailed information about Yemaachi Biotech. This is an essential first step to explore their research initiatives, as the company section typically provides insights into their mission, vision, and foundational projects that may lead to the research initiatives I need to investigate.

Action: click(121) # Click on the 'Company' link to explore more about Yemaachi Biotech.

Change Description: The state of the browser changed from displaying the main page of Yemaachi Biotech to the 'Company' page, which features a new heading 'A New Dawn for Health Knowledge in Africa' and sections detailing the company's work, vision, values, advisory team, and investor partnerships.

Screenshot before:Screenshot after:---

Step 2:

Url (before/after):

https://www.yemaachi.com/company/

https://www.yemaachi.com/research/

Content (before/after): 

RootWebArea Company – Yemaachi Biotech, focused, url='https://www.yemaachi.com/company/'
    banner
        [105] link, center=(512,65), url='https://www.yemaachi.com/'
            image, url='https://www.yemaachi.com/wp-content/uploads/2023/11/image-1.png'
        list
Show more 
            listitem
                [118] link Company, center=(750,65), url='https://www.yemaachi.com/company/'
            listitem
                [128] link Cancer Network, center=(888,65), url='https://www.yemaachi.com/cancer-network/'
            listitem
                [130] link Research, center=(1015,65), url='https://www.yemaachi.com/research/'
            listitem
                [132] link Services, center=(1112,65), url='https://www.yemaachi.com/services/'
            listitem
                [134] link News, center=(1196,65), url='https://www.yemaachi.com/news/'
        [145] link Contact Us, center=(1449,65), url='https://www.yemaachi.com/company/#'
    heading A New Dawn for Health Knowledge in Africa
    paragraph
        StaticText Yem is a Frafra (Northern Ghana) word meaning knowledge. Amaachi is derived from an Ewe (Eastern Ghana) word meaning medicine. Maachi is also Twi (Southern Ghana) phrase meaning good morning. Together, this conveys the meaning of our name Yemaachi: A new dawn for health knowledge in Africa.
    heading Our Work
    paragraph
        StaticText Yemaachi is creating the world’s most diverse cancer bio-database to develop the next generation of cancer drugs that are effective in diverse populations.
    heading Our Vision
    paragraph
        StaticText Yemaachi is working towards a future where precision oncology research, diagnostics, and therapeutics are truly inclusive, for the benefit of people everywhere.
    heading The values we live by
    paragraph
        StaticText Guiding principles shaping our actions daily.
    heading Respect
    paragraph
        StaticText Our work is based on a foundation of mutual respect between researchers and participants
    heading Empower
    paragraph
        StaticText Our research, products and services empower the communities that inspire and support our work
    heading People
    paragraph
        StaticText We maintain an ecosystem that ensures we put people ahead of profit
    heading Excellence
    paragraph
        StaticText We are commited to excellence in every area of our work
    heading Inclusivity
    paragraph
        StaticText We maintain a safe, open and positive environment
    heading Trust
    paragraph
        StaticText Our activities are conducted in a transparent and ethical manner
    heading Advisory Team
    link profile, url='javascript:void(0)'
        image, url='https://www.yemaachi.com/wp-content/uploads/2023/11/Yaw-Bediako-e1701773995490.jpg'
    heading profile
        link profile, url='javascript:void(0)'
            StaticText Yaw Bediako, PhD
    paragraph
        StaticText Co-Founder & CEO | Immunology
    link profile, url='javascript:void(0)'
        image, url='https://www.yemaachi.com/wp-content/uploads/2023/11/David-Hutchful-e1701774185672.jpg'
    heading profile
        link profile, url='javascript:void(0)'
            StaticText David Hutchful, MSc
    paragraph
        StaticText Co-Founder & CTO
    link profile, url='javascript:void(0)'
        image, url='https://www.yemaachi.com/wp-content/uploads/2023/12/8R4A0464copy-scaled-e1701773391468-1024x1024.jpg'
    heading profile
        link profile, url='javascript:void(0)'
            StaticText Joyce Ngoi, MSc
    paragraph
        StaticText Co-Founder | NGS | Technical Services
    link profile, url='javascript:void(0)'
        image, url='https://www.yemaachi.com/wp-content/uploads/2023/12/Yaw-Profic-Pic-Photo.jpeg'
    heading profile
        link profile, url='javascript:void(0)'
            StaticText Yaw Attua-Afari
    paragraph
        StaticText Co-Founder & CFO
    link profile, url='javascript:void(0)'
        image, url='https://www.yemaachi.com/wp-content/uploads/2023/12/leadership-1024x1024.jpg'
    heading profile
        link profile, url='javascript:void(0)'
            StaticText Abdoulaye Diallo, PhD
    paragraph
        StaticText Bioinformatics & Machine Learning
    link profile, url='javascript:void(0)'
        image, url='https://www.yemaachi.com/wp-content/uploads/2023/12/8R4A0438copy-scaled-e1702642405168-1024x1010.jpg'
    heading profile
        link profile, url='javascript:void(0)'
            StaticText Aida Manu, MSc
    paragraph
        StaticText Operations & Compliance
    link profile, url='javascript:void(0)'
        image, url='https://www.yemaachi.com/wp-content/uploads/2024/07/Dr.jpg'
    heading profile
        link profile, url='javascript:void(0)'
            StaticText Akwasi Asabere, PhD
    paragraph
        StaticText Business Development
    link profile, url='javascript:void(0)'
        image, url='https://www.yemaachi.com/wp-content/uploads/2023/12/8R4A0524copy-scaled-e1701774984824-1024x1024.jpg'
    heading profile
        link profile, url='javascript:void(0)'
            StaticText Emmanuella Amoako, MD
    paragraph
        StaticText Clinical Affairs | Oncology
    link profile, url='javascript:void(0)'
        image, url='https://www.yemaachi.com/wp-content/uploads/2023/11/Frank-Onyambu.jpg'
    heading profile
        link profile, url='javascript:void(0)'
            StaticText Frank Onyambu, PhD
    paragraph
        StaticText Training & Capacity Development | Country Representative, Kenya
    link profile, url='javascript:void(0)'
        image, url='https://www.yemaachi.com/wp-content/uploads/2023/12/leadership-1024x1024.jpg'
    heading profile
        link profile, url='javascript:void(0)'
            StaticText Kanny Diallo, PhD
    paragraph
        StaticText Molecular Epidemiology | Representative, Francophone Africa
    link profile, url='javascript:void(0)'
        image, url='https://www.yemaachi.com/wp-content/uploads/2023/12/8R4A0506copy-scaled-e1702642211658-1024x1020.jpg'
    heading profile
        link profile, url='javascript:void(0)'
            StaticText Lily Paemka, MPhil, PhD
    paragraph
        StaticText Human Genetics
    link profile, url='javascript:void(0)'
        image, url='https://www.yemaachi.com/wp-content/uploads/2023/12/SalewaAHeadshots-8-1-scaled-e1702642492195-1024x1024.jpg'
    heading profile
        link profile, url='javascript:void(0)'
            StaticText Salewa Akomolafe, MA
    paragraph
        StaticText Strategy & Planning
    heading Our Investors
    paragraph
        StaticText Yemaachi is backed by global investors, including V8 Capital, AAIC, LifeLine Family Heritage Fund, Y Combinator, Tencent, LoftyInc Capital, VestedWorld, V Square Capital and Ethan Perlstein, committed to our mission of diversifying precision oncology for the benefit of patients everywhere.
    group 1 of 5
        figure
            image Tencent, url='https://www.yemaachi.com/wp-content/uploads/2023/11/Tencent.jpg'
    group 2 of 5
        figure
            image Y Combinator, url='https://www.yemaachi.com/wp-content/uploads/2023/11/Y-Combinator.jpg'
    group 3 of 5
        figure
            image AAIC Investment, url='https://www.yemaachi.com/wp-content/uploads/2023/11/AAIC-Investment.jpg'
    group 4 of 5
        figure
            image VestedWOrld, url='https://www.yemaachi.com/wp-content/uploads/2023/11/VestedWOrld.jpg'
    group 5 of 5
        figure
            image V8 Capital Partners, url='https://www.yemaachi.com/wp-content/uploads/2023/11/V8-Capital-Partners.jpg'
    button Previous slide
    button Next slide
    generic, atomic
    heading Where We Work
    heading Academic & Research Partners
    heading Industry Partners
    heading Non-Profit Partners
    image, url='https://www.yemaachi.com/wp-content/uploads/2023/11/Marcelle-Ruth.jpg'
    image, url='https://www.yemaachi.com/wp-content/uploads/2023/11/Mask-group-1.png'
    image, url='https://www.yemaachi.com/wp-content/uploads/2023/11/Korle-Bu.png'
    image Greater Accra Regional Hospital logo, url='https://www.yemaachi.com/wp-content/uploads/2023/11/Ridge.png'
    image, url='https://www.yemaachi.com/wp-content/uploads/2023/11/cropped-KATH-LogoNEW.webp'
    image, url='https://www.yemaachi.com/wp-content/uploads/2023/11/Meru-Teching-Hospital.jpg'
    image, url='https://www.yemaachi.com/wp-content/uploads/2023/11/Federal-Teaching-Hospital.jpg'
    image, url='https://www.yemaachi.com/wp-content/uploads/2023/11/Amino-Kano.jpg'
    image, url='https://www.yemaachi.com/wp-content/uploads/2023/11/CHU.jpg'
    image, url='https://www.yemaachi.com/wp-content/uploads/2023/12/8R4A0775-1024x683.jpg'
    heading Join Us
    paragraph
        StaticText The Yemaachi team is a talented, passionate, and committed group of scientists, strategists, engineers, and operators.  Open roles will be posted
        link here, url='https://yemaachi.bamboohr.com/careers'
        StaticText .  To send us your resume or inquire about roles not posted, reach out at
        link recruitment@yemaachi.com, url='mailto:recruitment@yemaachi.com'
        StaticText .
    paragraph
        StaticText Yemaachi also offers internships by application for undergraduate and graduate students. Interns get valuable hands-on experience and mentorship and can focus on Finance, Bioinformatics, Molecular Biology, Software Engineering, or Marketing. To apply, please send a resume/CV, cover letter, and a recommendation from your institution or professor to
        link internships@yemaachi.com, url='mailto:internships@yemaachi.com'
        StaticText indicating which domain area you are interested in applying for.
    contentinfo
        image, url='https://www.yemaachi.com/wp-content/uploads/2022/07/Logo-6.png'
        heading Links
        list
            listitem
                link Company, url='https://www.yemaachi.com/company/'
            listitem
                link Cancer Network, url='https://www.yemaachi.com/cancer-network/'
            listitem
                link Research, url='https://www.yemaachi.com/research-2/'
            listitem
                link Services, url='https://www.yemaachi.com/services/'
            listitem
                link News, url='https://www.yemaachi.com/news/'
            listitem
                link Contact Us, url='https://www.yemaachi.com/contact/'
            listitem
                link Terms of Use, url='https://www.yemaachi.com/terms-of-use/'
            listitem
                link Privacy Notice, url='https://www.yemaachi.com/privacy-notice/'
        heading Contact Us
        list
            listitem
                link +233 502 528 528, url='tel://+233%20502%20528%20528'
            listitem
                link info@yemaachi.com, url='mailto://info@yemaachi.com'
        heading Company
        paragraph
            StaticText 222 Swaniker Street
            StaticText Abelemkpe – Accra
            StaticText GHANA
        paragraph
            StaticText 1250 Connecticut Ave
            StaticText Suite 700
            StaticText Washington DC 20036
            StaticText USA
        paragraph
            StaticText APHRC Campus
            StaticText Kitisuru, Nairobi
            StaticText KENYA
    StaticText We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
    [1056] button Cookie settings, center=(1755,1046)
    [1057] button ACCEPT, center=(1858,1046)
    StaticText desktop
    generic, atomic
    generic, atomic

RootWebArea Research – Yemaachi Biotech, focused, url='https://www.yemaachi.com/research/'
    banner
        [103] link, center=(512,65), url='https://www.yemaachi.com/'
            image, url='https://www.yemaachi.com/wp-content/uploads/2023/11/image-1.png'
        list
Show more 
            listitem
                [116] link Company, center=(750,65), url='https://www.yemaachi.com/company/'
            listitem
                [126] link Cancer Network, center=(888,65), url='https://www.yemaachi.com/cancer-network/'
            listitem
                [128] link Research, center=(1015,65), url='https://www.yemaachi.com/research/'
            listitem
                [130] link Services, center=(1112,65), url='https://www.yemaachi.com/services/'
            listitem
                [132] link News, center=(1196,65), url='https://www.yemaachi.com/news/'
        [143] link Contact Us, center=(1449,65), url='https://www.yemaachi.com/research/#'
    heading Clinical Research
    paragraph
        StaticText Yemaachi is developing the most diverse cancer knowledge base in the world and advancing clinical research across the African continent.  This research includes work to identify novel biomarkers for early detection of cancer among African populations and develop novel diagnostic tools based on these markers, as well as identify novel therapeutic targets that are extensible to broad populations.
    heading Yemaachi Cancer Knowledge Base
    paragraph
        StaticText The Yemaachi Cancer Knowledge Base is a first-of-its-kind bio-database that includes clinical and molecular data from across the African continent –  the world’s most genetically diverse human population.  We harness our unmatched network of clinical partners globally and our deep expertise in molecular biology, immunogenomics, and machine learning. Our goal is to develop the next generation of cancer drugs and diagnostic tools that are effective in diverse populations.
    heading Ongoing Studies
    heading Alive Study
    paragraph
        StaticText Contribution of genetic variation to the metabolism of drugs in tumour and pericarcinomatous liver fractions from hepatocellular carcinoma donors
    paragraph
        StaticText The ALIVE Study leverages the pharmacology expertise at H3D and the genomics and computational biology capacity at Yemaachi to understand how drug metabolism varies across the continent, with the aim of better optimizing treatment regimens for African populations.
    paragraph
    paragraph
    paragraph
    heading Amber Study
    paragraph
        strong
            StaticText Liquid Biopsy for Detection of Actionable Genomic Mutations in Women of African Descent with Advanced Breast Cancer
    paragraph
        StaticText The AMBER Study is a prospective, observational trial exploring the utility of a cfDNA liquid biopsy assay to identify actionable genetic mutations in metastatic breast cancer patients in Ghana.
    paragraph
    paragraph
    heading African Cancer Study
    paragraph
        strong
            StaticText Genetic Characterisation of Cancers in Africa
    paragraph
        StaticText This study aims to understand genetic factors mediating selected solid tumour cancers in Africans. Due to considerable differences in genetic diversity between African and Caucasian populations, largely Eurocentric cancer research findings are not fully representative of Africans.
    heading Heritage Study
    paragraph
        strong
            StaticText Investigating the immune kinetics of COVID-19 vaccine responses between European and African populations
    paragraph
        StaticText The purpose of this study is to understand immune response to the COVID-19 vaccine. This research study is led by Yemaachi Biotech Ltd, in partnership with Ghana Health Service, West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), Francis Crick Institute, and Bill & Melinda Gates Foundation.
    heading SeqCoM-Gh
    paragraph
        strong
            StaticText Sequencing for Covid Mitigation in Ghana
    paragraph
        StaticText A partnership between Yemaachi Biotech Ltd and the West African Centre for Cell Biology of Infectious Pathogens (WACCBIP) to provide critical real-time information on the evolution of the SARS-CoV-2 virus across Ghana.
    paragraph
    heading PROGRESS Study
    paragraph
        strong
            StaticText Paediatric Oncology in Ghana Research Sites
    paragraph
        strong
        StaticText The aim of this study is to improve childhood cancer survival in Ghana by advancing research into diagnosis, treatment, follow up and determinants of outcomes of 6 cancers prioritised by the Global Initiative for Childhood Cancers (GICC) – Acute Lymphoblastic Leukaemia (ALL), Burkitt Lymphoma, Hodgkin Lymphoma, Wilms Tumour, Retinoblastoma, and low-grade gliomas.
    heading Work With Us
    paragraph
        StaticText Interested in learning more about Yemaachi clinical research opportunities or the Yemaachi Cancer Knowledge Base? Are you a researcher who wants to contribute or work with de-identified data?
    link Contact Us, url='https://www.yemaachi.com/research/#'
    contentinfo
        image, url='https://www.yemaachi.com/wp-content/uploads/2022/07/Logo-6.png'
        heading Links
        list
            listitem
                link Company, url='https://www.yemaachi.com/company/'
            listitem
                link Cancer Network, url='https://www.yemaachi.com/cancer-network/'
            listitem
                link Research, url='https://www.yemaachi.com/research-2/'
            listitem
                link Services, url='https://www.yemaachi.com/services/'
            listitem
                link News, url='https://www.yemaachi.com/news/'
            listitem
                link Contact Us, url='https://www.yemaachi.com/contact/'
            listitem
                link Terms of Use, url='https://www.yemaachi.com/terms-of-use/'
            listitem
                link Privacy Notice, url='https://www.yemaachi.com/privacy-notice/'
        heading Contact Us
        list
            listitem
                link +233 502 528 528, url='tel://+233%20502%20528%20528'
            listitem
                link info@yemaachi.com, url='mailto://info@yemaachi.com'
        heading Company
        paragraph
            StaticText 222 Swaniker Street
            StaticText Abelemkpe – Accra
            StaticText GHANA
        paragraph
            StaticText 1250 Connecticut Ave
            StaticText Suite 700
            StaticText Washington DC 20036
            StaticText USA
        paragraph
            StaticText APHRC Campus
            StaticText Kitisuru, Nairobi
            StaticText KENYA
    StaticText We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
    [369] button Cookie settings, center=(1755,1046)
    [370] button ACCEPT, center=(1858,1046)
    StaticText desktop
    generic, atomic
    generic, atomic

Reasoning for action: I clicked on the 'Research' link because the next step in the user story requires me to explore Yemaachi Biotech's research initiatives. This action will redirect me to a page that likely contains information about various research projects, including clinical studies and specific contributions to cancer research, which is crucial to completing the user's task.

Action: click(130) # Click on the 'Research' link to explore Yemaachi Biotech's research initiatives.

Change Description: The browser state changed from the 'Company' page of Yemaachi Biotech to the 'Research' page, which details various clinical research initiatives, studies, and the Yemaachi Cancer Knowledge Base.

Screenshot before:Screenshot after:---

Step 3:

Url (before/after):

https://www.yemaachi.com/research/

https://www.yemaachi.com/research/

Content (before/after): 

RootWebArea Research – Yemaachi Biotech, focused, url='https://www.yemaachi.com/research/'
    banner
        [103] link, center=(512,65), url='https://www.yemaachi.com/'
            image, url='https://www.yemaachi.com/wp-content/uploads/2023/11/image-1.png'
        list
Show more 
            listitem
                [116] link Company, center=(750,65), url='https://www.yemaachi.com/company/'
            listitem
                [126] link Cancer Network, center=(888,65), url='https://www.yemaachi.com/cancer-network/'
            listitem
                [128] link Research, center=(1015,65), url='https://www.yemaachi.com/research/'
            listitem
                [130] link Services, center=(1112,65), url='https://www.yemaachi.com/services/'
            listitem
                [132] link News, center=(1196,65), url='https://www.yemaachi.com/news/'
        [143] link Contact Us, center=(1449,65), url='https://www.yemaachi.com/research/#'
    heading Clinical Research
    paragraph
        StaticText Yemaachi is developing the most diverse cancer knowledge base in the world and advancing clinical research across the African continent.  This research includes work to identify novel biomarkers for early detection of cancer among African populations and develop novel diagnostic tools based on these markers, as well as identify novel therapeutic targets that are extensible to broad populations.
    heading Yemaachi Cancer Knowledge Base
    paragraph
        StaticText The Yemaachi Cancer Knowledge Base is a first-of-its-kind bio-database that includes clinical and molecular data from across the African continent –  the world’s most genetically diverse human population.  We harness our unmatched network of clinical partners globally and our deep expertise in molecular biology, immunogenomics, and machine learning. Our goal is to develop the next generation of cancer drugs and diagnostic tools that are effective in diverse populations.
    heading Ongoing Studies
    heading Alive Study
    paragraph
        StaticText Contribution of genetic variation to the metabolism of drugs in tumour and pericarcinomatous liver fractions from hepatocellular carcinoma donors
    paragraph
        StaticText The ALIVE Study leverages the pharmacology expertise at H3D and the genomics and computational biology capacity at Yemaachi to understand how drug metabolism varies across the continent, with the aim of better optimizing treatment regimens for African populations.
    paragraph
    paragraph
    paragraph
    heading Amber Study
    paragraph
        strong
            StaticText Liquid Biopsy for Detection of Actionable Genomic Mutations in Women of African Descent with Advanced Breast Cancer
    paragraph
        StaticText The AMBER Study is a prospective, observational trial exploring the utility of a cfDNA liquid biopsy assay to identify actionable genetic mutations in metastatic breast cancer patients in Ghana.
    paragraph
    paragraph
    heading African Cancer Study
    paragraph
        strong
            StaticText Genetic Characterisation of Cancers in Africa
    paragraph
        StaticText This study aims to understand genetic factors mediating selected solid tumour cancers in Africans. Due to considerable differences in genetic diversity between African and Caucasian populations, largely Eurocentric cancer research findings are not fully representative of Africans.
    heading Heritage Study
    paragraph
        strong
            StaticText Investigating the immune kinetics of COVID-19 vaccine responses between European and African populations
    paragraph
        StaticText The purpose of this study is to understand immune response to the COVID-19 vaccine. This research study is led by Yemaachi Biotech Ltd, in partnership with Ghana Health Service, West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), Francis Crick Institute, and Bill & Melinda Gates Foundation.
    heading SeqCoM-Gh
    paragraph
        strong
            StaticText Sequencing for Covid Mitigation in Ghana
    paragraph
        StaticText A partnership between Yemaachi Biotech Ltd and the West African Centre for Cell Biology of Infectious Pathogens (WACCBIP) to provide critical real-time information on the evolution of the SARS-CoV-2 virus across Ghana.
    paragraph
    heading PROGRESS Study
    paragraph
        strong
            StaticText Paediatric Oncology in Ghana Research Sites
    paragraph
        strong
        StaticText The aim of this study is to improve childhood cancer survival in Ghana by advancing research into diagnosis, treatment, follow up and determinants of outcomes of 6 cancers prioritised by the Global Initiative for Childhood Cancers (GICC) – Acute Lymphoblastic Leukaemia (ALL), Burkitt Lymphoma, Hodgkin Lymphoma, Wilms Tumour, Retinoblastoma, and low-grade gliomas.
    heading Work With Us
    paragraph
        StaticText Interested in learning more about Yemaachi clinical research opportunities or the Yemaachi Cancer Knowledge Base? Are you a researcher who wants to contribute or work with de-identified data?
    link Contact Us, url='https://www.yemaachi.com/research/#'
    contentinfo
        image, url='https://www.yemaachi.com/wp-content/uploads/2022/07/Logo-6.png'
        heading Links
        list
            listitem
                link Company, url='https://www.yemaachi.com/company/'
            listitem
                link Cancer Network, url='https://www.yemaachi.com/cancer-network/'
            listitem
                link Research, url='https://www.yemaachi.com/research-2/'
            listitem
                link Services, url='https://www.yemaachi.com/services/'
            listitem
                link News, url='https://www.yemaachi.com/news/'
            listitem
                link Contact Us, url='https://www.yemaachi.com/contact/'
            listitem
                link Terms of Use, url='https://www.yemaachi.com/terms-of-use/'
            listitem
                link Privacy Notice, url='https://www.yemaachi.com/privacy-notice/'
        heading Contact Us
        list
            listitem
                link +233 502 528 528, url='tel://+233%20502%20528%20528'
            listitem
                link info@yemaachi.com, url='mailto://info@yemaachi.com'
        heading Company
        paragraph
            StaticText 222 Swaniker Street
            StaticText Abelemkpe – Accra
            StaticText GHANA
        paragraph
            StaticText 1250 Connecticut Ave
            StaticText Suite 700
            StaticText Washington DC 20036
            StaticText USA
        paragraph
            StaticText APHRC Campus
            StaticText Kitisuru, Nairobi
            StaticText KENYA
    StaticText We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
    [369] button Cookie settings, center=(1755,1046)
    [370] button ACCEPT, center=(1858,1046)
    StaticText desktop
    generic, atomic
    generic, atomic

RootWebArea Research – Yemaachi Biotech, focused, url='https://www.yemaachi.com/research/'
    banner
        [103] link, center=(512,65), url='https://www.yemaachi.com/'
            image, url='https://www.yemaachi.com/wp-content/uploads/2023/11/image-1.png'
        list
Show more 
            listitem
                [116] link Company, center=(750,65), url='https://www.yemaachi.com/company/'
            listitem
                [126] link Cancer Network, center=(888,65), url='https://www.yemaachi.com/cancer-network/'
            listitem
                [128] link Research, center=(1015,65), url='https://www.yemaachi.com/research/'
            listitem
                [130] link Services, center=(1112,65), url='https://www.yemaachi.com/services/'
            listitem
                [132] link News, center=(1196,65), url='https://www.yemaachi.com/news/'
        [143] link Contact Us, center=(1449,65), url='https://www.yemaachi.com/research/#'
    heading Clinical Research
    paragraph
        StaticText Yemaachi is developing the most diverse cancer knowledge base in the world and advancing clinical research across the African continent.  This research includes work to identify novel biomarkers for early detection of cancer among African populations and develop novel diagnostic tools based on these markers, as well as identify novel therapeutic targets that are extensible to broad populations.
    heading Yemaachi Cancer Knowledge Base
    paragraph
        StaticText The Yemaachi Cancer Knowledge Base is a first-of-its-kind bio-database that includes clinical and molecular data from across the African continent –  the world’s most genetically diverse human population.  We harness our unmatched network of clinical partners globally and our deep expertise in molecular biology, immunogenomics, and machine learning. Our goal is to develop the next generation of cancer drugs and diagnostic tools that are effective in diverse populations.
    heading Ongoing Studies
    heading Alive Study
    paragraph
        StaticText Contribution of genetic variation to the metabolism of drugs in tumour and pericarcinomatous liver fractions from hepatocellular carcinoma donors
    paragraph
        StaticText The ALIVE Study leverages the pharmacology expertise at H3D and the genomics and computational biology capacity at Yemaachi to understand how drug metabolism varies across the continent, with the aim of better optimizing treatment regimens for African populations.
    paragraph
    paragraph
    paragraph
    heading Amber Study
    paragraph
        strong
            StaticText Liquid Biopsy for Detection of Actionable Genomic Mutations in Women of African Descent with Advanced Breast Cancer
    paragraph
        StaticText The AMBER Study is a prospective, observational trial exploring the utility of a cfDNA liquid biopsy assay to identify actionable genetic mutations in metastatic breast cancer patients in Ghana.
    paragraph
    paragraph
    heading African Cancer Study
    paragraph
        strong
            StaticText Genetic Characterisation of Cancers in Africa
    paragraph
        StaticText This study aims to understand genetic factors mediating selected solid tumour cancers in Africans. Due to considerable differences in genetic diversity between African and Caucasian populations, largely Eurocentric cancer research findings are not fully representative of Africans.
    heading Heritage Study
    paragraph
        strong
            StaticText Investigating the immune kinetics of COVID-19 vaccine responses between European and African populations
    paragraph
        StaticText The purpose of this study is to understand immune response to the COVID-19 vaccine. This research study is led by Yemaachi Biotech Ltd, in partnership with Ghana Health Service, West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), Francis Crick Institute, and Bill & Melinda Gates Foundation.
    heading SeqCoM-Gh
    paragraph
        strong
            StaticText Sequencing for Covid Mitigation in Ghana
    paragraph
        StaticText A partnership between Yemaachi Biotech Ltd and the West African Centre for Cell Biology of Infectious Pathogens (WACCBIP) to provide critical real-time information on the evolution of the SARS-CoV-2 virus across Ghana.
    paragraph
    heading PROGRESS Study
    paragraph
        strong
            StaticText Paediatric Oncology in Ghana Research Sites
    paragraph
        strong
        StaticText The aim of this study is to improve childhood cancer survival in Ghana by advancing research into diagnosis, treatment, follow up and determinants of outcomes of 6 cancers prioritised by the Global Initiative for Childhood Cancers (GICC) – Acute Lymphoblastic Leukaemia (ALL), Burkitt Lymphoma, Hodgkin Lymphoma, Wilms Tumour, Retinoblastoma, and low-grade gliomas.
    heading Work With Us
    paragraph
        StaticText Interested in learning more about Yemaachi clinical research opportunities or the Yemaachi Cancer Knowledge Base? Are you a researcher who wants to contribute or work with de-identified data?
    link Contact Us, url='https://www.yemaachi.com/research/#'
    contentinfo
        image, url='https://www.yemaachi.com/wp-content/uploads/2022/07/Logo-6.png'
        heading Links
        list
            listitem
                link Company, url='https://www.yemaachi.com/company/'
            listitem
                link Cancer Network, url='https://www.yemaachi.com/cancer-network/'
            listitem
                link Research, url='https://www.yemaachi.com/research-2/'
            listitem
                link Services, url='https://www.yemaachi.com/services/'
            listitem
                link News, url='https://www.yemaachi.com/news/'
            listitem
                link Contact Us, url='https://www.yemaachi.com/contact/'
            listitem
                link Terms of Use, url='https://www.yemaachi.com/terms-of-use/'
            listitem
                link Privacy Notice, url='https://www.yemaachi.com/privacy-notice/'
        heading Contact Us
        list
            listitem
                link +233 502 528 528, url='tel://+233%20502%20528%20528'
            listitem
                link info@yemaachi.com, url='mailto://info@yemaachi.com'
        heading Company
        paragraph
            StaticText 222 Swaniker Street
            StaticText Abelemkpe – Accra
            StaticText GHANA
        paragraph
            StaticText 1250 Connecticut Ave
            StaticText Suite 700
            StaticText Washington DC 20036
            StaticText USA
        paragraph
            StaticText APHRC Campus
            StaticText Kitisuru, Nairobi
            StaticText KENYA
    StaticText We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
    [369] button Cookie settings, center=(1755,1046)
    [370] button ACCEPT, center=(1858,1046)
    StaticText desktop
    generic, atomic
    generic, atomic

Reasoning for action: By clicking on the 'Amber Study' heading, I am directly accessing the specific part of the webpage that contains the detailed description of this clinical trial. This action aligns with the user's goal to explore Yemaachi Biotech's research initiatives, particularly focusing on the Amber Study, which is crucial for understanding its contributions to cancer research.

Action: click(128) # Click on the 'Amber Study' heading to learn more about this specific study.

Change Description: The action of clicking on the 'Amber Study' heading resulted in the display of detailed information about the study's purpose and methodology, such as the focus on liquid biopsy for detecting actionable genomic mutations in women of African descent with advanced breast cancer.

Screenshot before:Screenshot after:---